Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Quality of Life Research
Erschienen in: Quality of Life Research 12/2020

01.07.2020

The influence of trait mindfulness on depression in multiple sclerosis: potential implications for treatment

verfasst von: Jennifer R. Miller, Caroline Altaras, Nicholas A. Vissicchio, Vance Zemon, Jeffrey G. Portnoy, Elizabeth S. Gromisch, Jessica Sloan, Tuula Tyry, Frederick W. Foley

Erschienen in: Quality of Life Research | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study seeks to add to existing literature on depression and illness intrusiveness in chronic disorders by examining, (1) how the perceived intrusiveness of multiple sclerosis (MS) leads to depression, (2) and the mediating role trait mindfulness plays in this relationship

Methods

Participants (N = 755) were persons with MS (PwMS) recruited through the North American Research Committee on MS (NARCOMS) registry (a larger study). Participants completed the Illness Intrusiveness Ratings Scale, the Hospital Anxiety and Depression Scale and the Mindful Attention Awareness Scale. A mediation model assessed if trait mindfulness mediates the relationship between illness intrusiveness and depression

Results

Illness intrusiveness predicted trait mindfulness (a =  − 4.54; p < .001), trait mindfulness predicted depression (b =  − .04; p < .001); there was a direct effect of illness intrusiveness on depression (c’ = 2.53; p < .001) and an indirect effect on depression (ab = .17, 95% BCa CI [.10, .25]) when trait mindfulness was in the model, which represented a medium size effect, R2med = .10 [95% CI .07, .14]

Conclusion

Trait mindfulness mediates the relationship between illness intrusiveness and depression in PwMS. Providers could provide psychoeducation on the benefits of mindfulness and mindfulness-based interventions.
Literatur
1.
Grossman, P., Kappos, L., Gensicke, H., D’Souza, M., Mohr, D. C., Penner, I. K., et al. (2010). MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology, 75(13), 1141–1149.PubMedPubMedCentral
2.
Patten, S. B., Marrie, R. A., & Carta, M. G. (2017). Depression in multiple sclerosis. International Review of Psychiatry, 29(5), 463–472.PubMed
3.
Marrie, R. A., Cohen, J., Stuve, O., Trojano, M., Sørensen, P. S., Reingold, S., et al. (2015). A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview. Multiple Sclerosis Houndmills Basingstoke England, 21(3), 263–281.
4.
Goldman Consensus Group. (2005). The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis Houndmills Basingstoke England, 11(3), 328–337.
5.
Feinstein, A. (2011). Multiple sclerosis and depression. Multiple Sclerosis Houndmills Basingstoke England, 17(11), 1276–1281.
6.
Feinstein, A. (2002). An examination of suicidal intent in patients with multiple sclerosis. Neurology, 59(5), 674–678.PubMed
7.
Feinstein, A., Magalhaes, S., Richard, J.-F., Audet, B., & Moore, C. (2014). The link between multiple sclerosis and depression. Nature Reviews Neurology, 10(9), 507–517.PubMed
8.
9.
Devins, G. M., Styra, R., O’connor, P., Gray, T., Seland, T. P., Klein, G. M., et al. (1996). Psychosocial impact of illness intrusiveness moderated by age in multiple sclerosis. Psychology Health & Medicine, 1(2), 179–191.
10.
Devins, G. M., Edworthy, S. M., Seland, T. P., Klein, G. M., Paul, L. C., & Mandin, H. (1993). Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. The Journal of Nervous and Mental Disease, 181(6), 377–381.PubMed
11.
Devins, G. M. (2010). Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. Journal of Psychosomatic Research, 68(6), 591–602.PubMed
12.
Mullins, L. L., Cote, M. P., Fuemmeler, B. F., Jean, V. M., Beatty, W. W., & Paul, R. H. (2001). Illness intrusiveness, uncertainty, and distress in individuals with multiple sclerosis. Rehabilitation Psychology, 46(2), 139–153.
13.
Hoff, A. L., Mullins, L. L., Chaney, J. M., Hartman, V. L., & Domek, D. (2002). Illness uncertainty, perceived control, and psychological distress among adolescents with type 1 diabetes. Research and Theory for Nursing Practice, 16(4), 223–236.PubMed
14.
LeMaire, W. A., Shahane, A., Dao, T., Kibler, J., & Cully, A. J. (2012). Illness intrusiveness mediates the relationship between heart failure severity and depression in older adults. Journal of Applied Gerontology, 31, 608.
15.
Renn, B. N., Hundt, N. E., Sansgiry, S., Petersen, N. J., Kauth, M. R., Kunik, M. E., et al. (2018). Integrated brief cognitive behavioral therapy improves illness intrusiveness in veterans with chronic obstructive pulmonary disease. Annals of Behavioral Medicine, 52(8), 686–696.PubMed
16.
Kiken, L. G., Garland, E. L., Bluth, K., Palsson, O. S., & Gaylord, S. A. (2015). From a state to a trait: Trajectories of state mindfulness in meditation during intervention predict changes in trait mindfulness. Personality and Individual Differences, 81, 41–46.PubMedPubMedCentral
17.
Baer, R. A., Smith, G. T., Lykins, E., Button, D., Krietemeyer, J., Sauer, S., et al. (2008). Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment, 15(3), 329–342.PubMed
18.
Schirda, B., Nicholas, J. A., & Prakash, R. S. (2015). Examining trait mindfulness, emotion dysregulation, and quality of life in multiple sclerosis. Health Psychology, 34(11), 1107–1115.PubMed
19.
Lynn Paukert, A., LeMaire, A., & Cully, A. J. (2009). Predictors of depressive symptoms in older veterans with heart failure. Aging & Mental Health, 13, 601.
20.
Devins, G. M., Edworthy, S. M., Guthrie, N. G., & Martin, L. (1992). Illness intrusiveness in rheumatoid arthritis: Differential impact on depressive symptoms over the adult lifespan. Journal of Rheumatology, 19(5), 709–715.PubMed
21.
Snyder, S., Foley, F. W., Farrell, E., Beier, M., & Zemon, V. (2013). Psychological and physical predictors of illness intrusiveness in patients with multiple sclerosis. Journal of the Neurological Sciences, 332(1), 41–44.PubMed
22.
Way, B. M., Creswell, J. D., Eisenberger, N. I., & Lieberman, M. D. (2010). Dispositional mindfulness and depressive symptomatology: Correlations with limbic and self-referential neural activity during rest. Emotion, 10(1), 12–24.PubMedPubMedCentral
23.
Modinos, G., Ormel, J., & Aleman, A. (2010). Individual differences in dispositional mindfulness and brain activity involved in reappraisal of emotion. Social Cognitive and Affective Neuroscience, 5(4), 369–377.PubMedPubMedCentral
24.
Gromisch, E. S., Sloan, J., Zemon, V., Tyry, T., Schairer, L. C., Snyder, S., et al. (2018). Development of the multiple sclerosis resiliency scale (MSRS). Rehabilitation Psychology, 63(3), 357.PubMed
25.
Rickham, P. P. (1964). Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. The BMJ, 2(5402), 177.PubMed
26.
Marrie, R. A., Cutter, G., Tyry, T., Campagnolo, D., & Vollmer, T. (2007). Validation of the NARCOMS registry: Diagnosis. Multiple Sclerosis Houndmills Basingstoke England, 13(6), 770–775.
27.
Tan-Kristanto, S., & Kiropoulos, L. A. (2015). Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis. Psychology Health & Medicine, 20(6), 635–645.
28.
Gromisch, E. S., Portnoy, J. G., & Foley, F. W. (2018). Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS). Journal of the Neurological Sciences, 388, 70–75.PubMed
29.
Antel, J., Antel, S., Caramanos, Z., Arnold, D. L., & Kuhlmann, T. (2012). Primary progressive multiple sclerosis: Part of the MS disease spectrum or separate disease entity? Acta Neuropathologica, 123(5), 627–638.PubMed
30.
Bieling, P. J., Rowa, K., Antony, M. M., Summerfeldt, L. J., & Swinson, R. P. (2001). Factor structure of the illness intrusiveness rating scale in patients diagnosed with anxiety disorders. Journal of Psychopathological and Behavioral Assessment, 23(4), 223–230.
31.
Devins, G. M., Beanlands, H., Mandin, H., & Paul, L. C. (1997). Psychosocial impact of illness intrusiveness moderated by self-concept and age in end-stage renal disease. Health Psychology, 16(6), 529–538.PubMed
32.
Honarmand, K., & Feinstein, A. (2009). Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Multiple Sclerosis Houndmills Basingstoke England, 15(12), 1518–1524.
33.
Marrie, R. A., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., et al. (2018). The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Multiple Sclerosis and Related Disorders, 20, 9–15.PubMed
34.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMed
35.
Black, D. S. (2010). Mindfulness research guide: A new paradigm for managing empirical health information. Mindfulness, 1(3), 174–176.PubMedPubMedCentral
36.
Simpson, R., Mair, F. S., & Mercer, S. W. (2017). Mindfulness-based stress reduction for people with multiple sclerosis—A feasibility randomised controlled trial. BMC Neurology, 17(1), 94.PubMedPubMedCentral
37.
Brown, K. W., & Ryan, R. M. (2003). The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology, 84(4), 822–848.PubMed
38.
Allison, P. D. (2001). Missing data (p. 100). Thousand Oaks: SAGE Publications.
39.
Hayes A. F. (2012). Process: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling 1.
40.
Hayes, A. F., & Preacher, K. J. (2010). Quantifying and testing indirect effects in simple mediation models when the constituent paths are nonlinear. Multivariate Behavioral Research, 45(4), 627–660.PubMed
41.
Higuera, L., Carlin, C. S., & Anderson, S. (2016). Adherence to disease-modifying therapies for multiple sclerosis. Journal of Managed Care & Specialty Pharmacy, 22(12), 1394–1401.
42.
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001). Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Multiple Sclerosis Journal, 7(5), 340–344.PubMed
43.
Cash, M., & Whittingham, K. (2010). What facets of mindfulness contribute to psychological well-being and depressive, anxious, and stress-related symptomatology? Mindfulness, 1(3), 177–182.
44.
Dianati, F. A., Moheb, N., & Amiri, S. (2016). Is mindfulness a mediator factor in obsessive compulsive disorder? Journal of Research in Clinical Medicine, 4(4), 196–202.
Metadaten
Titel
The influence of trait mindfulness on depression in multiple sclerosis: potential implications for treatment
verfasst von
Jennifer R. Miller
Caroline Altaras
Nicholas A. Vissicchio
Vance Zemon
Jeffrey G. Portnoy
Elizabeth S. Gromisch
Jessica Sloan
Tuula Tyry
Frederick W. Foley
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 12/2020
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02567-6

Weitere Artikel der Ausgabe 12/2020

Quality of Life Research 12/2020 Zur Ausgabe

OriginalPaper

The importance of development standards for anchoring vignettes: an illustrative example from pediatric localized scleroderma quality of life

OriginalPaper

Risk models for predicting the health-related quality of life of caregivers of youth with gastrointestinal concerns

OriginalPaper

Social cohesion and quality of life among survivors of a natural disaster

OriginalPaper

Quality of life and distress assessed with self and external assessment screening tools in patients with hematologic malignancies attending treatment in an acute hospital

OriginalPaper

Physical activity status in relation to quality of life and dietary habits in breast cancer survivors: subset analyses of KROG 14-09 nationwide questionnaire study

Letter to the Editor

Registered Reports: response from the Chinese PRO SIG